• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tiny bubbles get past blood-brain barrier for targeted drug delivery

June 26, 2017 By Sarah Faulkner

Bubbles as drug deliveryThe blood-brain barrier plays an important role in protecting the human brain from harmful toxins. But it also stops potentially helpful drugs from reaching the brain. Now, researchers believe that tiny bubbles loaded with drugs and delivered using ultrasound could overcome the obstacles presented by the protective network of vessels.

Researchers at the University of Oxford and the University of Twente have developed an in vitro experimental platform that they believe could aid investigations into the way the blood-brain barrier opens, how long it takes to close again and the sounds given off as it opens.

“The key advantage of our system is that it uses three modalities — involving light, sound, and electrical fields — to simultaneously monitor acoustic emissions, blood-brain barrier disruption and recovery, and the biological response of blood-brain barrier cells in real-time,” Miles Aron, from the University of Oxford, said in prepared remarks.

Using ultrasound to open the blood-brain barrier is not a new idea – researchers have been trying to do it since the 1950s.

There are a number of cavitation agents, like tiny bubbles, approved by the FDA to boost contrast in ultrasound imaging. These agents oscillate rapidly when exposed to ultrasound, helping to open the blood-brain barrier.

“The treatment can be monitored externally by ‘listening’ to the re-radiated sound from the cavitation agents interacting with the ultrasound field. These acoustic emissions provide information regarding the energy of cavitation within the blood vessels and are already being used to adjust ultrasound parameters in real-time to reduce the likelihood of damaging healthy cells during treatment,” Aron said.

The team monitored the integrity of the barrier, as well as acoustic emissions, in real-time throughout treatment. Traditionally, researchers can only assess how well a delivery method penetrated the blood-brain barrier after a treatment is finished.

The team also used fluorescent probes to assess changes in the cells throughout treatment.

“By analyzing multiple sources of data during ultrasound exposure and throughout BBB recovery, we aim to better understand this promising new treatment,” Aron said. “With the Oxford Centre for Drug Delivery Devices, OxCD3, we are currently working on a non-invasive method to detect and treat brain metastases before they become deadly. Our in vitro system will play a critical role in the development of this and other next-generation approaches to ultrasound-mediated blood brain barrier opening.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news

Filed Under: Featured, Neurological, Pharmaceuticals, Research & Development Tagged With: universityofoxford, universityoftwente

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS